Papapetropoulos Spyros
CIK: 0001832694
Primary company: Adamas Pharmaceuticals Inc (ADMS)
Papapetropoulos Spyros is a corporate insider at Adamas Pharmaceuticals Inc (ADMS) filing SEC Form 4 transactions. 22 transactions across 4 companies, totaling $54,042 in purchases and $4,200 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 34,559 | $8.27 | $286K | 74,088 | 8/27/2025 Filed: 9/2/2025 | Filing → | |
Lipocine Inc. LPCN | Award | 1,764 | $3.20 | $6K | 7,174 | 6/4/2025 Filed: 6/5/2025 | Filing → |
| Award | 27,000 | $5.16 | $139K | 39,529 | 4/16/2025 Filed: 5/19/2025 | Filing → | |
| Award | 270,000 | $5.16 | $1.39M | 282,529 | 4/16/2025 Filed: 4/18/2025 | Filing → | |
Lipocine Inc. LPCN | Award | 1,764 | $7.05 | $12K | 5,410 | 6/5/2024 Filed: 6/7/2024 | Filing → |
Lipocine Inc. LPCN | Award | 30,000 | $0.27 | $8K | 62,000 | 5/10/2023 Filed: 5/12/2023 | Filing → |
Lipocine Inc. LPCN | Purchase | 21,739 | $0.47 | $10K | 21,739 | 11/22/2022 Filed: 11/28/2022 | Filing → |
| Exercise | 300 | $0.00 | $0 | 149,604 | 11/18/2022 Filed: 11/22/2022 | Filing → | |
| Sale | 300 | $14.00 | $4K | 4,000 | 11/18/2022 Filed: 11/22/2022 | Filing → | |
| Exercise | 300 | $1.89 | $567 | 4,300 | 11/18/2022 Filed: 11/22/2022 | Filing → | |
Lipocine Inc. LPCN | Award | 22,000 | $0.92 | $20K | 32,000 | 6/8/2022 Filed: 6/10/2022 | Filing → |
| Purchase | 4,000 | $3.40 | $14K | 4,000 | 5/3/2022 Filed: 5/4/2022 | Filing → | |
Lipocine Inc. LPCN | Award | 10,000 | $1.16 | $12K | 10,000 | 4/11/2022 Filed: 4/12/2022 | Filing → |
| Award | 75,500 | $0.00 | $0 | 75,500 | 3/1/2022 Filed: 3/3/2022 | Filing → | |
Adamas Pharmaceuticals Inc ADMS | Disposition | 10,000 | - | - | 0 | 11/24/2021 Filed: 11/24/2021 | Filing → |
Adamas Pharmaceuticals Inc ADMS | Disposition | 20,000 | - | - | 0 | 11/24/2021 Filed: 11/24/2021 | Filing → |
Adamas Pharmaceuticals Inc ADMS | U | 20,975 | - | - | 0 | 11/24/2021 Filed: 11/24/2021 | Filing → |
Adamas Pharmaceuticals Inc ADMS | Award | 10,000 | $0.00 | $0 | 10,000 | 6/2/2021 Filed: 6/4/2021 | Filing → |
Adamas Pharmaceuticals Inc ADMS | Award | 5,000 | $0.00 | $0 | 20,975 | 6/2/2021 Filed: 6/4/2021 | Filing → |
Adamas Pharmaceuticals Inc ADMS | Purchase | 5,975 | $5.06 | $30K | 15,975 | 3/11/2021 Filed: 3/15/2021 | Filing → |
Type
Award
Shares
34,559
Price
$8.27
Value
$286K
Lipocine Inc.
LPCN
Type
Award
Shares
1,764
Price
$3.20
Value
$6K
Type
Award
Shares
27,000
Price
$5.16
Value
$139K
Type
Award
Shares
270,000
Price
$5.16
Value
$1.39M
Lipocine Inc.
LPCN
Type
Award
Shares
1,764
Price
$7.05
Value
$12K
Lipocine Inc.
LPCN
Type
Award
Shares
30,000
Price
$0.27
Value
$8K
Lipocine Inc.
LPCN
Type
Purchase
Shares
21,739
Price
$0.47
Value
$10K
Type
Exercise
Shares
300
Price
$0.00
Value
$0
Type
Sale
Shares
300
Price
$14.00
Value
$4K
Type
Exercise
Shares
300
Price
$1.89
Value
$567
Lipocine Inc.
LPCN
Type
Award
Shares
22,000
Price
$0.92
Value
$20K
Type
Purchase
Shares
4,000
Price
$3.40
Value
$14K
Lipocine Inc.
LPCN
Type
Award
Shares
10,000
Price
$1.16
Value
$12K
Type
Award
Shares
75,500
Price
$0.00
Value
$0
Adamas Pharmaceuticals Inc
ADMS
Type
Disposition
Shares
10,000
Price
-
Value
-
Adamas Pharmaceuticals Inc
ADMS
Type
Disposition
Shares
20,000
Price
-
Value
-
Adamas Pharmaceuticals Inc
ADMS
Type
U
Shares
20,975
Price
-
Value
-
Adamas Pharmaceuticals Inc
ADMS
Type
Award
Shares
10,000
Price
$0.00
Value
$0
Adamas Pharmaceuticals Inc
ADMS
Type
Award
Shares
5,000
Price
$0.00
Value
$0
Adamas Pharmaceuticals Inc
ADMS
Type
Purchase
Shares
5,975
Price
$5.06
Value
$30K
AI Agent
Try asking...